Bill and Danielle Gottfried established The Kidney Research Institute of Texas and The Bill and Danielle Gottfried Foundation to support investment in kidney disease research in The Texas Medical Center in Houston and in other medical centers in the U.S. and international areas. We are initiating a capital campaign in 2021 to raise investment for kidney disease research, kidney disease prevention, and technology innovation to improve patient care, including the acceleration of dialysis technology innovation and renal replacement therapies. We are committed to improving the lives of kidney patients. This Institute was established in memory of family members who have suffered from, and died from, kidney disease, including Bill Gottfried's Father, Henry William Gottfried, Jr.
We are conducting a search for the best and brightest Nephrologists, kidney research specialists, and advanced technology innovators to join our Advisory Board with the goal to accelerate investment in kidney disease prevention, research, and technology innovation to improve the lives of kidney patients. Our goal is to address the global pandemic of kidney disease and help end the suffering of kidney patients. One-third of the world's population is at risk for kidney disease.
We support clients in U.S. and international markets.
Offices and Partners in Houston, Washington, D.C., London, Paris